News thumbnail
Health / Mon, 17 Aug 2026 Gastroenterology Advisor

Add-On Tirzepatide May Reduce MACE Risk in People With T2D, ASCVD - Gastroenterology Advisor

Add-On Tirzepatide May Reduce MACE Risk in People With T2D, ASCVD Gastroenterology Advisor

Add-On Tirzepatide May Reduce MACE Risk in People With T2D, ASCVD Gastroenterology Advisor

© All Rights Reserved.